Application of human adipose tissue-derived stem cells for heart disease

Zhu YX,Song KD,Liu TQ
DOI: https://doi.org/10.3321/j.issn:1673-8225.2007.15.039
2007-01-01
Abstract:OBJECTIVE: To review the bionomics of adipose tissue-derived stem cells and its application in ischemic heart disease, analyze its deficiencies, list some problems to be resolved in the future, and then provide evidences for clinical treatment. DATA SOURCES: Relevant English articles of adipose tissue-derived stem cells and ischemic heart disease were searched in Blackwell, Elsevier and Pubmed databases published from 1980 to 2007 with the key words "bone mesenchymal stem cells, adipose derived stem cells, cardiomyocytes, ischemic heart disease". Meanwhile, a computer-based search was conducted in China Journal Full-text Database with the key words of "bone mesenchymal stem cells, adipose derived stem cells, cardiomyocytes, ischemic heart disease" published between 1980 and 2007. The relevant data were also consulted in libraries books by hand. STUDY SELECTION: The literatures were selected initially: ①bionomics of adipose tissue-derived stem cells, ②adipose tissue-derived stem cells for ischemic heart disease. Literatures with repetitive content were excluded. DATA EXTRACTION: Totally 57 articles were selected firstly, and the articles were excluded due to the repetition of the same research or unrelated with the subjects. The rest 41 articles were selected for the review references. DATA SYNTHESIS: There was similar bionomics of adipose tissue-derived stem cells and bone mesenchymal cells, and the cell-surface marker spectrum was also very similar. Source of adipose tissue was wide, and the materials were drawn conveniently. Stroma cells could be largely obtained. The cells were easy to culture and amplify. It found that without any induction the adipose tissue-derived stem cells cultured in vitro could differentiate into autorhythmic myocardial cells. The therapy of adipose tissue-derived stem cells for ischemic heart disease was possible. CONCLUSION: The material source and proliferation of adipose tissue-derived stem cells is superior to bone mesenchymal stem cells. Adipose tissue-derived stem cells can be better induced into cardiomyocytes, which provides a wide prospect for ischemic heart disease.
What problem does this paper attempt to address?